UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 239

Sortiert nach

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

Ophthalmology (Rochester, Minn.), 2009-01, Vol.116 (1), p.57-65.e5

2009

Volltextzugriff (PDF)

Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2013-05, Vol.120 (5), p.1046-1056

2013

Volltextzugriff (PDF)

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

The Lancet (British edition), 2017-07, Vol.390 (10089), p.50-61

2017

Volltextzugriff (PDF)

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2012-12, Vol.119 (12), p.2537-2548

2012

Volltextzugriff (PDF)

Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study

Ophthalmology (Rochester, Minn.), 2014-02, Vol.121 (2), p.535-544

2014

Volltextzugriff (PDF)

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

The New England journal of medicine, 2006-10, Vol.355 (14), p.1432-1444

2006

Volltextzugriff (PDF)

Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2014-07, Vol.121 (7), p.1414-1420.e1

2014

Volltextzugriff (PDF)

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

Ophthalmology (Rochester, MN), 2009-09, Vol.116 (9), p.1731-1739

2009

Volltextzugriff (PDF)

Vascular endothelial growth factor and diabetic macular edema

Survey of ophthalmology, 2016-11, Vol.61 (6), p.759-768

2016

Volltextzugriff (PDF)

Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration

Proceedings of the National Academy of Sciences - PNAS, 2011-04, Vol.108 (15), p.6241-6245

2011

Volltextzugriff (PDF)

Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid

Ophthalmology (Rochester, Minn.), 2016-09, Vol.123 (9), p.1856-1864

2016

Volltextzugriff (PDF)

Expanded Criteria for Pneumatic Retinopexy and Potential Cost Savings

Ophthalmology (Rochester, Minn.), 2014, Vol.121 (1), p.318-326

2014

Volltextzugriff (PDF)

The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good

JAMA ophthalmology, 2017-03, Vol.135 (3), p.268

2017

Volltextzugriff (PDF)

Noninfectious Inflammation After Intravitreal Injection of Aflibercept: Clinical Characteristics and Visual Outcomes

American journal of ophthalmology, 2014-10, Vol.158 (4), p.733-737.e1

2014

Volltextzugriff (PDF)

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

Ophthalmology (Rochester, Minn.), 2015-03, Vol.122 (3), p.545-554

2015

Volltextzugriff (PDF)

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

Ophthalmology (Rochester, Minn.), 2011-06, Vol.118 (6), p.1098-1106

2011

Volltextzugriff (PDF)

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2006-04, Vol.113 (4), p.623-632.e1

2006

Volltextzugriff (PDF)

Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2011-06, Vol.118 (6), p.1089-1097

2011

Volltextzugriff (PDF)

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab

Retina (Philadelphia, Pa.), 2008-11, Vol.28 (10), p.1395

2008

Volltextzugriff (PDF)

Outcomes after Failed Pneumatic Retinopexy for Retinal Detachment

Ophthalmology (Rochester, Minn.), 2016-05, Vol.123 (5), p.1137-1142

2016

Volltextzugriff (PDF)

Choroidal Neovascularization Secondary to Myopia, Infection and Inflammation

Developments in ophthalmology, 2016-01, Vol.55, p.167

2016

Volltextzugriff (PDF)

The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye

International journal of retina and vitreous, 2020-10, Vol.6 (1), p.48-11, Article 48

2020

Volltextzugriff (PDF)

Inclusion of Genotype with Fundus Phenotype Improves Accuracy of Predicting Choroidal Neovascularization and Geographic Atrophy

Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1880-1892

2013

Volltextzugriff (PDF)

Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration

Journal of clinical medicine, 2021-03, Vol.10 (7), p.1355

2021

Volltextzugriff (PDF)

Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical Trial

Ophthalmology (Rochester, Minn.), 2011, Vol.118 (1), p.111-118

2011

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Humanities

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(238)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Ophthalmology
(144)
Life Sciences & Biomedicine
(140)
Humans
(138)
Female
(92)
Male
(90)
Aged
(75)
Middle Aged
(55)
Treatment Outcome
(52)
Aged, 80 And Over
(46)
Visual Acuity - Physiology
(44)
Biological And Medical Sciences
(40)
Intravitreal Injections
(40)
Medical Sciences
(40)
Visual Acuity
(38)
Angiogenesis Inhibitors - Therapeutic Use
(34)
Tomography, Optical Coherence
(33)
Fluorescein Angiography
(31)
Macular Degeneration
(31)
Double-Blind Method
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

Vascular endothelial growth factor and diabetic macular edema

Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration

Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid

Expanded Criteria for Pneumatic Retinopexy and Potential Cost Savings

The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good

Noninfectious Inflammation After Intravitreal Injection of Aflibercept: Clinical Characteristics and Visual Outcomes

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

Tolerability and Efficacy of Multiple Escalating Doses of Ranibizumab (Lucentis) for Neovascular Age-Related Macular Degeneration

Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration

Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab

Outcomes after Failed Pneumatic Retinopexy for Retinal Detachment

Choroidal Neovascularization Secondary to Myopia, Infection and Inflammation

The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye

Inclusion of Genotype with Fundus Phenotype Improves Accuracy of Predicting Choroidal Neovascularization and Geographic Atrophy

Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration

Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical Trial

Aktive Filter

Suchergebnisse filtern